Zenas BioPharma (ZBIO) Net Equity Issued and Repurchased (2023 - 2026)
Zenas BioPharma's Net Equity Issued and Repurchased came in at $581,000 for Q2 2026, down 66.3% from $1.72 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zenas BioPharma reported Net Equity Issued and Repurchased of $3.45 million, up 89.3% year-over-year; for FY2025, it came in at $4.1 million, down 97.7% from FY2024.
- Going back by year, Net Equity Issued and Repurchased was $178.38 million in FY2024 and $116,000 in FY2023.
- The Q2 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
- Year-over-year, Net Equity Issued and Repurchased increased in two of the last five quarters, with growth averaging 73.7%.
- Business Quant data shows ZBIO's Net Equity Issued and Repurchased at $592,000 (Q1 2026), $1.61 million (Q4 2025) and $664,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Zenas BioPharma | 1.71 Bn | 1.71 Bn | - | 581,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 581,000.00 |
| Mar 31, 2026 | 592,000.00 |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 664,000.00 |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 99,000.00 |
| Jun 30, 2024 | 178.34 Mn |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 50,000.00 |
API Access
Zenas BioPharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();